The recall was announced after samples of the food item tested positive for salmonella, the FDA added. The good news is that no illnesses have been reported so far.

FDA names former pharmaceutical company executive to oversee US drug program As the agency’s top drug regulator, Tidmarsh will be charged with following through on a number of commitments made ...

The agency halts muscular dystrophy drug trials after 3 deaths from liver failure.

Find specific lot numbers on the FDA's website. A press release has not been issued for the recall as of yet. The status of the recall is ongoing.

Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with side effects, proposed dosing and a lack of diversity in GSK's trials.

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster vaccine for adult patients.

The FDA is reevaluating GlaxoSmithKline’s blood cancer drug Blenrep following mixed results from two phase 3 trials and mounting concerns about eye-related side effects and dosing. The agency is ...

Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis Kezar Life Sciences ...

Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune ...

SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA ... SELLAS Life Sciences Group, Inc. - (GLOBE NEWSWIRE) Jul 15, 2025 ...

With Law Firm Diversity Efforts Under Scrutiny, ACTL Forges Ahead With Trial Advocacy Program 6 minute read July 15, 2025 ...

The FDA has rejected Capricor Therapeutics’ filing for approval of a Duchenne muscular dystrophy (DMD) cell therapy, raising questions about whether the agency's new leadership may be rowing ...